Biotech OSE Immunotherapeutics draws buyers on the stock market

OSE Immunotherapeutics sees the purchase of 25,000 shares by investors.

Published 3sem1 sourceupdated 5j

≈ 17sSpeed

The fact

The transaction occurs on June 30 on the Paris market, despite valuation debates.

The biotech sector remains volatile, but some bet on therapeutic breakthroughs.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on June 30, 2026